Drug profile

The FDA adverse-event record for Sulfadiazine Sodium And Pyrimethamine

21 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Sulfadiazine Sodium And Pyrimethamine. See the species affected, top reactions, and outcomes below.

21
adverse-event reports
0.0%
death-coded share
Horse
most-reported species
4
Behavioural disorder NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
21
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Sulfadiazine Sodium And Pyrimethamine

Administration Routes

OralUnknownOtherOphthalmic

Species Affected

Horse 12
Unknown 6
Donkey 2
Human 1

Most Affected Breeds

Unknown 7
Thoroughbred 2
Quarter Horse 2
Morgan 2
Horse (unknown) 1
Warmblood (unspecified) 1
Donkey (other) 1
Tennessee Walking Horse 1
Mustang 1
Donkey (unknown) 1

Most Reported Reactions

Behavioural disorder NOS 4
Fever 2
Leucopenia NOS 2
Eye irritation 2
Precipitate, Sediment 2
Joint swelling 1
Difficulty to rise 1
Lack of efficacy - NOS 1
Colitis 1
Erythema (for urticaria see Immune SOC) 1
Warm feeling to the touch 1
Alopecia local 1

Outcome Breakdown

Outcome Unknown
11 (73.3%)
Recovered/Normal
3 (20.0%)
Ongoing
1 (6.7%)

Sulfadiazine Sodium And Pyrimethamine Adverse Event Insights

21 reports name Sulfadiazine Sodium And Pyrimethamine; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Sulfadiazine Sodium And Pyrimethamine. Administration routes: Oral, Unknown, Other, Ophthalmic.

By species: Horse (12 reports), Unknown (6 reports), Donkey (2 reports). By breed: Unknown (7), Thoroughbred (2), Quarter Horse (2).

Leading clinical signs: Behavioural disorder NOS (4), Fever (2), Leucopenia NOS (2), Eye irritation (2). Outcome, 15 coded reports: Outcome Unknown leads at 73.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.